Breast cancer in Iran: An epidemiological review

Breast Journal

Volumn 13, Issue 4, 2007, Pages 383-391

  Mousavi, Seyed Mohsen ^a,c   Montazeri, Ali ^b   Mohagheghi, Mohammad Ali ^a   Jarrahi, Alireza Mousavi ^a   Harirchi, Iraj ^a   Najafi, Masomeh ^b   Ebrahimi, Mandana ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Iranian Center for Breast Cancer   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Breast cancer; Epidemiology; Iran; Review

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER INCIDENCE; CANCER INFILTRATION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; HISTOLOGY; HUMAN; IRAN; KNOWLEDGE; LYMPH NODE METASTASIS; MOOD DISORDER; PATIENT ATTITUDE; PREVALENCE; PROGNOSIS; TUMOR VOLUME;

AGE DISTRIBUTION; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; INCIDENCE; IRAN; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREVALENCE;

EID: 34250859393     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00446.x     Document Type: Article

References (87)

1. Screening for Breast Cancer. http://www.who.int/cancer/detection/ breastcancer/en/
2. American Cancer Society. Cancer Facts and Figures 2005. Atlanta: American Cancer society, 2005. 9
3. Breast cancer facts and figures 2001. Atlanta: American Cancer Society, 2001.
4. Goya M. Iranian Annual Cancer Registration Report 2003. Ministry of Health and Medical Education, Health Deputy, Center for Disease Control and Prevention. March 2005 (Persian).
5. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev 2004 5: 24 27.
6. Mohagheghi MA, Mousavi Jarrahi AR, Mortazavi H, et al. Final report of National Cancer Registry modeling in Tehran. Tehran, Shahid Beheshti, and Iran universities of Health and medical services Cancer Institute, and Ministry of Health report 2002 12: 107 116.
7. Naghavi M. Mortality views in 18 Provinces of Iran 2001. Ministry of Health, Deputy to Health Directory, Research and development office, 2003 75 (Persian)
8. Cady B. Breast cancer in the third millennium. Breast J 2000 6: 280 87.
9. WHO Model for Cancer Control, http://www.ispt.ro/supercourse/lecture/ lec0701/020.htm 2005. Accessed June 20, 2006.
10. Harirchi I, Ghaem-Maghami F, Karbakhsh M, Moghimi R, Mazaheri H. Patient delay in women presenting with advanced breast Cancer, a study from Iran. Public Health 2005 119: 885 91.
11. Assadi K, Ovjee MR, Vahdat S, Shams S, Hghshenas M, Poursalimi SH. Breast cancer screening in Bushehr port population aged 30-65 years. South Med. J 1998 1: 217 22. NO 1
12. Talei AR, Sadeghi-Hassanabadi A, Saalabian J, et al. A Preliminary Report On Breast Cancer Screening Program In Shiraz Southern Iran. Irn J Med Sci 1997 22: 148.
13. Abbasalizadeh S, Abbasalizadeh F, Sahaf F, Navaei N. Prevalence of breast cancer in north west of Tabriz. Iranian J Obstetr Gyn 2002 5: 54 57.
14. Tofigh M, Anaraki P. Clinical and pathologic aspects of Breast mass in Moddares general hospital of Tehran from 1988-2002. Pajouhandeh J Med 2004 39: 175 177.
15. Ebrahimi M, Vahdaninia1 M, Montazeri A. Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res 2002 4: 1 4.
16. Yavari P, Mosavizadeh M, Sadrol-Hefazi B, Mehrabi Y. Reproductive characteristics and the risk of breast cancer-a case-control study in Iran. Asian Pac J Cancer Prev 2005 6: 370 75.
17. Sedagaht M, Nojomi M, Hosseini N. A case control study about risk factor of breast cancer in Iran. J Med Council IRI 2003 21: 198 204. (Persian)
18. Fathinajafi T, Jabarzadehgangeh S, Mojahedirezaeian S, Mazlom SR. Risk factors of breast cancer in women at fertility age in Mashad from 2002-2003. Iran Med J 2004 42: 577 85.
19. Aminisani N, Shamshirgaran SM, Ghavam Nasiri MR, Setayesh Y. The direct and indirect effect of smoking on breast cancer. Babol Med J 2004 7: 63 67 (Persian).
20. Atar Parsaei F, Golchin M, Asodi I. Association between personality, social, life style characteristics with breast cancer in women. Tabriz Med J 2001 35: 12 19 (Persian).
21. Motamed N, Hadi N, Talei A. Risk factors of breast cancer in women over 35 years old in Shiraz in 2001. Zanjan Med J 2004 12: 25 33 (Persian).
22. Aminisani N, Ghavamnasiri MR, Shamshirgaran SM, Ehdaeivand F, Mohageri M. Association between fertility indicators and Risk factors of Breast cancer. Mashhad Med J 2004 85: 307 312.
23. Mehdipour P, Atri M, Jafarimojarrad E, Hosseini-Asl SS, Javidroozi M. Laddering through pedigrees: family history of malignancies in primary breast cancer patients. Asian Pac J Cancer Prev 2003 4: 185 92.
24. Kashfi F, Nikofar AR, Mohammadi R. Fertility factors associated with breast cancer. Fertility Infertility J 2001 3: 38 45 (Persian).
25. Pesaran Z, Rezaei A, Tavakoloi R, Siadat AH. Assessment of Risk factors of Breast cancer to finding a replacement therapy with Hormone in women who received corticosteroids. Shahrekord Med J 2003 2: 70 75 (Persian).
26. Montazeri A, Haji-Mahmoodi M, Jarvandi S. Breast self-examination: do religious beliefs matter? A descriptive study. J Public Health Med 2003 25: 154 5.
27. Jarvandi S, Montazeri A, Harirchi I, Kazemnejad A. Beliefs and behaviors of Iranian teachers toward early detection of breast cancer and breast self-examination. Public Health 2002 116: 245 49.
28. Montazeri A, Haghighat S, Vahdani M, Jarvandi S, Harirchi I. Evaluation of a national breast cancer information service: the Iranian experience. Support Care Cancer 1999 7: 154 57.
29. Vahdani M, Montazeri A. Survival rate of breast cancer. Asian Pac J Cancer Prev 2004 5: 223 25.
30. Vahdaninia MS, Gila S, Montazeri A. Quality life as prognostic factor for breast cancer's 5 year survival rate. Payesh 2004 4: 39 45.
31. Mortazavi SH, Azadeh P, Valaei N. Prognostic Value of HER2 Oncoprotein in premenopausal women with breast cancer and axillary lymphadenopathy. Pajouhandeh Med J 2003 8: 7 13. (Persian).
32. Mortazavi SH, Ameri A. Association between time of surgery in different period with prognosis of Breast cancer. Pajouhandeh Med J 2002 7: 265 69 (Persian).
33. Fallahazad V, Kamalian N, Gransar A. The prevalence of Estrogen and progestron receptors in Breast cancer in Shariati general hospital of Tehran 2000-2002. J Tehran Med. Faculty 2004 62: 745 48 (Persian).
34. Behjati F, Atri M, Najmabadi H, Nouri K, Zamani M, Mehdipour P. Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among Iranian women: an interphase FISH analysis. Pathol Oncol Res 2005 11: 157 63.
35. Mokhtari M, Sobhan A, Roozbehi H. Epidermal growth factor in Breast cancer and its association with lymph adenopathy. Zanjan Med J 2003 44: 15 18 (Persian).
36. Mofid B, Jalalinodoshan MR, Kiani L, Zayeri F. Association between protooncogen HER2 with prognostic factor of Breast cancer. J Medical faculty, University of Shaheed Beheshti 2004 28: 29 32 (Persian).
37. Sirati F, Yadegari K. Association between HER_2 tumor marker with invasiveness of breast cancer in patient whom were done mastectomy in Cancer Institute from 2001-2003. Iran Med J 2004 11: 781 89 (Persian).
38. Kamali-Sarvestani E, Talei AR, Merat A. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women. Cancer Lett 2004 215: 83 7.
39. Razavi FM, Malaknia N, Farazi B. Catapsin D enzyme in Breast cancer. Mazandaran Med J 2001 31: 10 14 (Persian).
40. Siratisabet M, Karamitehrani F, Tghikhani M, Atri M. Free prolactin receptor in Breast cancer. Ghazvin Med. J 2000 14: 44 51 (Persian).
41. Kadivar M, Shafiee AM. The comparison evaluation of AgNOR index in the malignant and benign breast masses. Iran Med J 2002 9: 399 404 (Persian).
42. Ghaderi A, Talei A, Gharesi-Fard B, Farjadian SH, Amirzargar A. Vasei M.HLA-DRB1 alleles and the susceptibility of Iranian patients with breast cancer. Pathol Oncol Res 2001 7: 39 41.
43. Yassaee VR, Zeinali S, Harirchi I, et al. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res 2002 4: 1 6. Epub 2002 Apr 16.
44. Pietschmann A, Mehdipour P, Mehdipour P, et al. Mutation analysis of BRCA1 and BRCA2 genes in Iranian high risk breast cancer families. J Cancer Res Clin Oncol 2005 131: 552 58.
45. Teimori H, Poorparvin M, Atri M, Mirzaei MR. Mutation in the exons 3, 10, 12 of BRCA1 in 30 breast cancers with positive family history. Gorgan Med J 2001 3: 19 24 (Persian).
46. Etemadi K, Poorparvin M. P53 gene mutation in breast cancer with polymerase chain reaction single strand conformation polymorphism. Hamadan Med J 2002 4: 60 65 (Persian).
47. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 2005 225: 261 6.
48. Rajavi J, Moezi-Ghadim H. A breast cancer with metastasis to Oveal system. Feiz Med J 2000 16: 110 115.
49. Ameli J. A case report of breast cancer with peripheral neuropathy. Kosar Med J 2001 6: 41 44 (Persian).
50. Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A. Delayed presentation in breast cancer: a study in Iranian women. BMC Women's Health Available from: http://www.biomedcentral.com/1472-6874/3/4
51. Jalali Nodoshan MR, Hashemi M, Valaei N. Association between blood group and prognosis of breast cancer. Zanjan Med J 2002 10 (Persian).
52. Ramezani T. Depression and Phsychological consultation among breast cancer in chemotherapy centers of Kerman. Andisheh va Raftar 2001 6: 10 4 (Persian).
53. Montazeri A, Jarvandi S, Ebrahimi M, Haghighat S, Ansari M. The role of depression in the development of breast cancer: analysis of registry data from a single institute. Asian Pac J Cancer Prev 2004 5: 316 19.
54. Montazeri A, Harirchi I, Vahdani M, et al. Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Eur J Cancer Care (Engl) 2000 9: 151 57.
55. Montazeri A, Jarvandi S, Haghighat S, et al. Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns 2001 45: 195 98.
56. Haghighat S, Akbari ME, Holakouei K, Rahimi A, Montazeri A. Factors predicting fatigue in breast cancer patients. Support Care Cancer 2003 11: 533 38.
57. Montazeri A, Vahdaninia1 M, Ebrahimi M, Jarvandi S. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health and Quality of Life Outcomes This article is available from: http://www.hqlo.com/content/1/1/14
58. Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and use of complementary medicine among breast cancer patients. Support Care Cancer 2005;13:339-42.
59. Najafi M, Ebrahimi M, Hashemi E, Kaviani A. Breast conserving surgery versus mastectomy: cancer practice by general surgeons in Iran. BMC Cancer 2005 5: 35.
60. Hashemi E, Kaviani A, Najafi M, Ebrahimi M, Hooshmand H, Montazeri A. Seroma formation after surgery for breast cancer. World J Surg Oncol 2004 2: 44.
61. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health 2000 114: 143 5.
62. Dabiri S, Monsefi N, Nikian Y, Mirshekari TR, Rahimimoghadam MR. The Histological finding importance for treatment deciding in Breast cancer. Kerman Med J 1999 7: 26 33 (Persian).
63. Salsali M, Tazejani D, Javadi A, et al. A study of the clinical features and the treatment of breast cancer in 374 patients in Iran. Tumori 2003 89: 132 35.
64. Kamehshian T, Mazochi T. Family history in 100 cases of Breast cancer. Faiz Med J 2003 28: 90 94 (Persian).
65. Salsali M, Shiabi S, Derakhshan M, et al. The effect of health center in treatment of Breast cancer. Pajouhesh Med., Faculty Med. J 2001 25: 241 235 (Persian).
66. Atri M, Mehdipour P, Javidroozi M, Hosseini-asl SS, Jafarimojarrad E. Linking histopathology and family history in breast cancer. Asian Pacific J Cancer Prevent 2002 3: 33 39.
67. Azarhoosh R, Golalipoor MJ, Behnampoor N, Basharkhah A. Grading of malignant breast tumors according to histological characteristics. Gorgan Med J 1999 4: 32 38 (Persian).
68. Silanian Tosi F. The effect of hormone replacement therapy on of screening mammography's efficacy in menopauses. Univ Lett J 2004 14: 76 83 (Persian).
69. Sina A, Jalili A, Abdi B, Ghareaghaji R. Study of mammography findings and correlation of breast tumors with the pathological results in Emam general hospital of Urmia. J Urmia Univ Med 2002 13: 213 219 (Persian).
70. Daghagheleh H, Davaei M, Rakhshan M. The efficacy of FNA for detecting breast mass and its pathological result. Research in Med 2000 24: 287 90 (Persian).
71. Mahbobi A, Alvandi S, Alizadehnavaei R. Assessment of breast legions in Mammography. Babol Med. J 2004 2: 52 55 (Persian).
72. Dabiri S, Sedighi B. Sensitivity and specificity of FNA in women breast mass. Hamadan Med. J 2002 9: 1 5 (Persian).
73. Ahmadinegad N, Shahriaran S, Ghasemifirouzabadi A, Guiti M. Sensitivity and specificity of Doppler Sonography and Power Doppler for detecting malignant and benign breast mass in Emam hospital 1999-2000. Tehran Med. J 2002 60: 277 82 (Persian).
74. Naderi T, Bahrampoor A. Sensitivity and Specificity of breast mass detection by Behvarz in Health House. Kerman Med. J 2000 7: 73 78 (Persian).
75. Omranpoor R, Haghshenas S, Guiti M. Efficacy of axillary Sonography before surgery for detecting Metastatic lymph adenoma in Breast cancer (Emam hospital 2000-2001). Tehran Med J 2003 61: 359 63 (Persian).
76. Modir A, Mirshamsi MH, Hashemian M. FNA in breast tumors and compare with gross pathology. Yazd Med J 2001 9: 28 31 (Persian).
77. Hasaniesfahani M, Mousavi SR, Azargashb A. Efficacy of FNA for detecting Breast mass. Pajouhandeh Journal of Shahid Beheshti Medical University 2001 6: 527 29 (Persian).
78. Zakavi SR, Mehrabibahar M, Hadadiaval M. Efficacy of Breast scan with TC-MIBI for breast mass detection. Mashhad Med J 2004 47: 141 36 (Persian).
79. Talei A, Bostanian F. Accuracy of mammography for detecting of malignant breast lesions. J Med Council 2003 21: 22 26 (Persian).
80. Ziaeian B, Roodbary M. Comparison between FNA and biopsy for palpable breast mass. Ophogh e Danesh 2004 10: 31 35 (Persian).
81. Jokar F, Ghyasi N. Knowledge, attitude and practice of Ilamoan women about breast cancer. Ilam Med J 2000 9: 29 34 (Persian).
82. Danesh A, Amiri M, Zamani AR, Tazhibi M, Gangi F. Knowledge, attitude and practice of Sharekord women staff of Educational office about breast self exam. Sharekord Med J 2002 4: 47 52 (Persian).
83. Ramezani Tehrani F, Kazem M, Baroti E. Knowledge, attitude and practice of Iranian women 20-49 years old on Breast Cancer. Teb va Tazkieh 2001 42: 30 37 (Persian).
84. Dadkhah B, Mohammadi MA. Knowledge, attitude and practice of Ardebilian women about BSE in 2001. Ardebil Med J 2002 1: 15 20 (Persian).
85. Abedzadeh M, Sadat Z, Saberi F. Knowledge, attitude and practice of women who refer to rural health centers of Kashan about breast cancer and its case findings methods in 2001. Feiz Med J 2003 7: 85 92 (Persian).
86. Haji-Mahmoodi M, Montazeri A, Jarvandi S, Ebrahimi M, Haghighat S, Harirchi I. Breast self-examination: knowledge, attitudes, and practices among female health care workers in Tehran, Iran. Breast J 2002 8: 222 5.
87. Mahori K, Sadeghi Hasanabadi A, Talei A. Knowledge and practice of women who refer to rural health centers of Shiraz about breast cancer screening. Hormozgan Med J 2003 7: 0 0 (Persian).